{"name":"Risen (Suzhou) Pharma Tech Co., Ltd.","slug":"risen-suzhou-pharma-tech-co-ltd","ticker":"","exchange":"","domain":"","description":"Risen (Suzhou) Pharma Tech Co., Ltd. is a biotechnology company focused on the development of innovative therapies, particularly in oncology. The company has a pipeline of three drugs in various stages of clinical development, including Fulvestrant 50 Mg/mL Intramuscular Solution and JS105, both in Phase 3 trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"JS105","genericName":"JS105","slug":"js105","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"JS105","genericName":"JS105","slug":"js105","phase":"phase_3","mechanism":"JS105 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQbWllQkxUeEEya2V2eUc5aEotZ0V3Sl9FcHRtMmpEUjJrcGstdi0yY2JkNlc4SE4tbGZydjhKaVlIRG1XQ1VKQ2tRRHRuaXlJYmtKN3dfbUtBVkhGV0RBODU2Q2ltRHdrbE1lWGp2MDR2azZ2ZUdBNzVoQjFBUF9Ic1ktTDdBRnNpcjNQR2RvNlNOQ2haMENR?oc=5","date":"2026-02-17","type":"patent","source":"BioWorld News","summary":"Ascentage Pharma Group patents BTK PROTAC degraders - BioWorld News","headline":"Ascentage Pharma Group patents BTK PROTAC degraders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbzktb0ZpdUxHb0NIMGN5SjFBWG4zTjRCNmdqbHh4ZndyMjRfNHR6Yk1HNXpBVF93d1BlbzBNNGJfSXNNbnh4cGlxbFFiRmpwMmV4Vkd3WHJycDhfM1ZEZE1PcGVBb1htTVM0OW56cFBlZmVXV3FnZjdWcWtqZXV6aEY4RTFqODFNbUFfNVlOeW9kUm5BQUVhXzhudktUOWcxdUdWVlZtLVA?oc=5","date":"2025-08-06","type":"pipeline","source":"BioSpace","summary":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive - BioSpace","headline":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPMHpIVVFZcG9CYnJOMFJIcG55UkkydE9GaWJqaWFMZ2wyamljTkVKcGF3Ul83QVB3ak9mM1BOenFlLXEtNWNfZkZCSkhlTVozaGRZc21xU0UzUnNJZGh2aTdTc2JtSWFrejV5WkxodW0tMzRxWVFLUmhUMmtjc1RjcDJPSV8zNXowRGc?oc=5","date":"2025-01-16","type":"pipeline","source":"BioPharma Dive","summary":"‘The bar has risen’: China’s biotech gains push US companies to adapt - BioPharma Dive","headline":"‘The bar has risen’: China’s biotech gains push US companies to adapt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPVmNaTjZBdXN1bmpEdlQtUmc2aVBsWk5wczdOVWZ4THBGcDBkM1lKRlphbmdwczhRd2VCWmJQQUR0ak5hNGEtdDNhYTh3Zm8zTzd0VEpUek1uVmZzYkRmUHNSOVdfeFpRRVVkZGhpa3U1b0VIeUVtRXhlM3dIYVlCNnVIbm5IVmUxdHlDelFocnQwVl90bUEwN3JmOUVhY05lM0E?oc=5","date":"2024-08-06","type":"pipeline","source":"BioWorld News","summary":"Risen Pharma identifies new PROTACS for KRAS-driven cancers - BioWorld News","headline":"Risen Pharma identifies new PROTACS for KRAS-driven cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQWS1SWGhZSlpkUndMVHJmZnA5clBub053NHpKR0YzRnQ3SGo5MmZ6RTNpWHc4VU5HYkNaQXpIeXl1RUFZREZBRktRVFZ4eF9GWWNhY1lWWjE0Q0pyU0JYRkE0TXM2VEtoeTZPT0h0VmdYQk9Zd2R6dlE4STdJYlF0SXVwZUFBU3AtZnc?oc=5","date":"2024-07-30","type":"pipeline","source":"Information Technology and Innovation Foundation (ITIF)","summary":"How Innovative Is China in Biotechnology? | Reports & Briefings | Jul 30, 2024 - Information Technology and Innovation Foundation (ITIF)","headline":"How Innovative Is China in Biotechnology? | Reports & Briefings | Jul 30, 2024 - Information Technology and Innovation F","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQTkgtTUV5clJfWGNrUGFkY0VhX1h2Z3h2VE5XQVlnbkdSVDFUMDk2aFVzWDk4ZHZtVGtLS29ueUpWSzJkZGhGZzJQQWIzTXpoTWx2dTR1M1JiQUQ0Ml9zcHN5WUd4Qi1ZNkdVdExYaVBla1RObVN0YWUyR1VUMFFLN1FiSElUOG5xWlBnNS01cmNwUlQwVGlFRTFn?oc=5","date":"2024-07-11","type":"pipeline","source":"DCAT Value Chain Insights","summary":"The CDMO/CMO Report: Strong Growth Drives Contract ADC Market - DCAT Value Chain Insights","headline":"The CDMO/CMO Report: Strong Growth Drives Contract ADC Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNTlNzNzJlUUEtUWxmNGYyYURnM1dBU3VDMTFHeVNzZ3J1aFNqZm92X2lGUlNSM3g2UUU2b19XQ2lIa1NiVzBld0t0VXBRNUVMY3pUdGs3ZDItdFhaRkdqNmRadE5mZ0NkclVKaHNsUTczNFluUW9QcUQ5R2xzQWhQV1c0YXFqT250cHdpeFJkd0xBaDlGWlFaN3ZoZw?oc=5","date":"2022-07-15","type":"regulatory","source":"The Malaysian Reserve","summary":"Pharmaniaga boosts production to meet higher demand - The Malaysian Reserve","headline":"Pharmaniaga boosts production to meet higher demand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQTDAzZzcwQjM1ZnFUT3duVGNNM1pWYzh3Z2tseDlLcXdXNDJhcHRIejVvNklVUXZETEJwV2RoOVZKZmJUY1MtcEhwQWgwY04yNXBLd3N6SGNiTGpKcnZuM05ycG5JdEN6ZHBPWnkxb21iZWlfQlhIa3JGWGwtbElFcXctYzc?oc=5","date":"2022-07-08","type":"earnings","source":"IPWatchdog.com","summary":"Patent Filings Roundup: Suits Explode at End of Q2 - IPWatchdog.com","headline":"Patent Filings Roundup: Suits Explode at End of Q2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPWXpld2dTdFlxeTdZUVFJYlVadTFTQll2MnEyVExtZkNtemVjT3A1bTFLODJQVXBMdlhzaDdWdDZrZk8telpqTldoVVgyel9EckVHa0VwWlRNbzhqYXZBdkkwbEtqOF9yd1BtSW9hdnQ2bnJxYXhrRHFEYmpEWGhvNzN1UlJZbkVkUC13NHZPbVI3ZjNQMjZSNEFmUVN3NVVUcFRGVi00cUZHdGNWQnkyeDBVUHZfVWR4RzBBU1JHMFRHQW1ZN0F0LWFOTjFiajd4MWhIVDNzMjQ?oc=5","date":"2019-05-17","type":"pipeline","source":"BioProcess International","summary":"China Looks Inward and Outward: Investments in US and EU Biopharmaceutical Companies Are on the Rise - BioProcess International","headline":"China Looks Inward and Outward: Investments in US and EU Biopharmaceutical Companies Are on the Rise","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}